Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Cholestyramine - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic sources for cholestyramine and what is the scope of patent protection?

Cholestyramine is the generic ingredient in eight branded drugs marketed by Parke Davis, Ani Pharms Inc, Ivax Sub Teva Pharms, Par Pharm, Sandoz, Teva, Zydus Pharms, Teva Pharms, Upsher Smith Labs, Bristol Myers, and Apothecon, and is included in nineteen NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for cholestyramine. Eight suppliers are listed for this compound.

Drug Prices for cholestyramine

See drug prices for cholestyramine

Recent Clinical Trials for cholestyramine

Identify potential brand extensions & 505(b)(2) entrants

Pharmascience Inc.Phase 2
University of Illinois at ChicagoPhase 1
Pierre and Marie Curie UniversityPhase 4

See all cholestyramine clinical trials

Pharmacology for cholestyramine
Synonyms for cholestyramine

US Patents and Regulatory Information for cholestyramine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz CHOLESTYRAMINE cholestyramine POWDER;ORAL 074557-002 Aug 15, 1996 AB RX No No   Start Trial   Start Trial   Start Trial
Sandoz LOCHOLEST cholestyramine POWDER;ORAL 074561-001 Aug 15, 1996 DISCN No No   Start Trial   Start Trial   Start Trial
Teva CHOLESTYRAMINE cholestyramine POWDER;ORAL 074347-001 May 28, 1998 DISCN No No   Start Trial   Start Trial   Start Trial
Bristol Myers QUESTRAN LIGHT cholestyramine POWDER;ORAL 019669-003 Dec 5, 1988 DISCN Yes No   Start Trial   Start Trial   Start Trial
Bristol Myers QUESTRAN cholestyramine POWDER;ORAL 016640-001 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
Apothecon QUESTRAN cholestyramine TABLET;ORAL 073403-001 Apr 28, 1994 DISCN No No   Start Trial   Start Trial   Start Trial
Ivax Sub Teva Pharms CHOLESTYRAMINE cholestyramine POWDER;ORAL 074771-002 Jul 9, 1997 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.